PPD opens new offices in Philippines and India to extend in contract research reach in growing Asian markets

19 February 2010

PPD, a USA-based contract research organization, has announced the opening of offices in Manila, Philippines, and Bangalore, India, expanding its Phase II-IV clinical development services in response to growing client demand in the Asia/Pacific region. PPD will provide clinical management services in key therapeutic areas from both locations.

The offices strengthen PPD's full range of drug discovery and development services and continue to position the company to capitalize on the tremendous growth of the outsourcing market in Asia Pacific. PPD recently expanded in this region through its acquisitions of Excel, the market leader and one of the largest CROs in China, and BioDuro, a drug discovery outsourcing company, the US CRO noted.

'With 90 million people living in the Philippines and more than 20 million in Manila, there is enthusiasm for local expansion and involvement in clinical trials,' said Lesley Gerrard, director of clinical management in PPD's Melbourne, Australia, office. 'The recent opening of the Manila office demonstrates PPD's commitment to the growth and development of emerging markets in Southeast Asia and to further exploration of the opportunities that exist within this region,' he added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical